Mesa Laboratories Price to Sales Ratio 2010-2024 | MLAB
Historical PS ratio values for Mesa Laboratories (MLAB) over the last 10 years. The current P/S ratio for Mesa Laboratories as of May 21, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Mesa Laboratories P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-05-21 | 111.97 | 2.56 | |
| 2024-12-31 | 131.71 | $43.81 | 3.01 |
| 2024-09-30 | 129.53 | $42.14 | 3.07 |
| 2024-06-30 | 86.45 | $41.44 | 2.09 |
| 2024-03-31 | 109.16 | $40.14 | 2.72 |
| 2023-12-31 | 104.07 | $39.58 | 2.63 |
| 2023-09-30 | 104.18 | $39.79 | 2.62 |
| 2023-06-30 | 127.27 | $40.88 | 3.11 |
| 2023-03-31 | 172.85 | $41.02 | 4.21 |
| 2022-12-31 | 164.26 | $41.69 | 3.94 |
| 2022-09-30 | 139.05 | $42.01 | 3.31 |
| 2022-06-30 | 201.18 | $37.76 | 5.33 |
| 2022-03-31 | 251.24 | $34.78 | 7.22 |
| 2021-12-31 | 323.20 | $31.16 | 10.37 |
| 2021-09-30 | 297.70 | $27.37 | 10.88 |
| 2021-06-30 | 266.83 | $26.74 | 9.98 |
| 2021-03-31 | 239.45 | $26.57 | 9.01 |
| 2020-12-31 | 281.71 | $26.99 | 10.44 |
| 2020-09-30 | 250.23 | $27.57 | 9.08 |
| 2020-06-30 | 212.80 | $27.40 | 7.77 |
| 2020-03-31 | 221.79 | $27.42 | 8.09 |
| 2019-12-31 | 244.50 | $26.15 | 9.35 |
| 2019-09-30 | 232.94 | $25.50 | 9.14 |
| 2019-06-30 | 239.20 | $25.73 | 9.30 |
| 2019-03-31 | 225.51 | $25.58 | 8.82 |
| 2018-12-31 | 203.74 | $26.15 | 7.79 |
| 2018-09-30 | 181.34 | $25.81 | 7.03 |
| 2018-06-30 | 206.05 | $25.50 | 8.08 |
| 2018-03-31 | 144.76 | $25.00 | 5.79 |
| 2017-12-31 | 121.07 | $24.19 | 5.00 |
| 2017-09-30 | 145.27 | $24.10 | 6.03 |
| 2017-06-30 | 139.26 | $24.64 | 5.65 |
| 2017-03-31 | 119.11 | $24.41 | 4.88 |
| 2016-12-31 | 119.00 | $24.69 | 4.82 |
| 2016-09-30 | 110.74 | $23.79 | 4.65 |
| 2016-06-30 | 118.93 | $23.19 | 5.13 |
| 2016-03-31 | 93.01 | $22.53 | 4.13 |
| 2015-12-31 | 95.88 | $21.01 | 4.56 |
| 2015-09-30 | 107.19 | $20.63 | 5.20 |
| 2015-06-30 | 85.41 | $19.95 | 4.28 |
| 2015-03-31 | 69.24 | $19.54 | 3.54 |
| 2014-12-31 | 73.99 | $18.81 | 3.93 |
| 2014-09-30 | 55.18 | $17.54 | 3.15 |
| 2014-06-30 | 80.01 | $15.97 | 5.01 |
| 2014-03-31 | 85.84 | $14.64 | 5.86 |
| 2013-12-31 | 74.61 | $13.86 | 5.38 |
| 2013-09-30 | 64.07 | $13.46 | 4.76 |
| 2013-06-30 | 51.19 | $13.24 | 3.87 |
| 2013-03-31 | 49.78 | $13.06 | 3.81 |
| 2012-12-31 | 47.14 | $12.67 | 3.72 |
| 2012-09-30 | 45.38 | $12.22 | 3.71 |
| 2012-06-30 | 43.49 | $11.72 | 3.71 |
| 2012-03-31 | 46.01 | $11.46 | 4.01 |
| 2011-12-31 | 38.56 | $11.70 | 3.29 |
| 2011-09-30 | 32.78 | $11.23 | 2.92 |
| 2011-06-30 | 29.20 | $10.76 | 2.71 |
| 2011-03-31 | 26.51 | $10.29 | 2.58 |
| 2010-12-31 | 27.51 | $8.76 | 3.14 |
| 2010-09-30 | 20.99 | $8.09 | 2.60 |
| 2010-06-30 | 21.83 | $7.39 | 2.95 |
| 2010-03-31 | 23.46 | $6.66 | 3.52 |
| 2009-12-31 | 23.25 | $6.46 | 3.60 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.627B | $0.216B |
| MESA LABORATORIES, INC. designs, develops, acquires, manufactures and markets instruments and systems utilized in connection with industrial applications and hemodialysis therapy. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $199.696B | 87.47 |
| Thermo Fisher Scientific (TMO) | United States | $156.188B | 18.89 |
| Edwards Lifesciences (EW) | United States | $45.655B | 29.93 |
| Alcon (ALC) | Switzerland | $43.440B | 29.36 |
| IDEXX Laboratories (IDXX) | United States | $41.591B | 47.80 |
| DexCom (DXCM) | United States | $34.247B | 52.93 |
| IQVIA Holdings (IQV) | United States | $25.076B | 14.05 |
| Mettler-Toledo (MTD) | United States | $24.648B | 29.31 |
| STERIS (STE) | Ireland | $24.609B | 27.14 |
| Waters (WAT) | United States | $21.548B | 30.40 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.213B | 0.00 |
| Hologic (HOLX) | United States | $12.584B | 13.67 |
| Penumbra (PEN) | United States | $10.887B | 85.45 |
| Sysmex ADR (SSMXY) | Japan | $10.571B | 29.99 |
| Globus Medical (GMED) | United States | $8.473B | 19.87 |
| Masimo (MASI) | United States | $8.467B | 31.23 |
| Teleflex (TFX) | United States | $5.606B | 9.25 |
| Glaukos (GKOS) | United States | $5.571B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.243B | 22.23 |
| TransMedics (TMDX) | United States | $4.218B | 91.70 |
| PROCEPT BioRobotics (PRCT) | United States | $3.274B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.447B | 14.57 |
| Veracyte (VCYT) | United States | $2.256B | 31.66 |
| Elekta AB (EKTAY) | Sweden | $2.106B | 18.93 |
| Nihon Kohden (NHNKY) | Japan | $2.058B | 23.60 |
| Alphatec Holdings (ATEC) | United States | $1.896B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.567B | 0.00 |
| Artivion (AORT) | United States | $1.246B | 116.68 |
| Pulse Biosciences (PLSE) | United States | $1.148B | 0.00 |
| OPKO Health (OPK) | United States | $1.055B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.035B | 5.50 |
| SiBone (SIBN) | United States | $0.840B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.687B | 0.00 |
| IRadimed (IRMD) | United States | $0.678B | 34.38 |
| RxSight (RXST) | United States | $0.675B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.626B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.606B | 9.42 |
| NeuroPace (NPCE) | United States | $0.590B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.556B | 0.00 |
| AxoGen (AXGN) | United States | $0.527B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.468B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.467B | 12.43 |
| Treace Medical Concepts (TMCI) | United States | $0.421B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.386B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.358B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.306B | 0.00 |
| Neuronetics (STIM) | United States | $0.282B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.242B | 14.65 |
| Alpha Tau Medical (DRTS) | Israel | $0.229B | 0.00 |
| CVRx (CVRX) | United States | $0.182B | 0.00 |
| Accuray (ARAY) | United States | $0.179B | 0.00 |
| 908 Devices (MASS) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.173B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.169B | 0.00 |
| Inogen (INGN) | United States | $0.169B | 0.00 |
| LENSAR (LNSR) | United States | $0.165B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.141B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.140B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.138B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.136B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.122B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.099B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.095B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.084B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.079B | 48.00 |
| EDAP TMS S.A (EDAP) | France | $0.071B | 0.00 |
| InspireMD (NSPR) | Israel | $0.067B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.066B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.056B | 17.08 |
| Hyperfine (HYPR) | United States | $0.048B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.044B | 0.00 |
| Envoy Medical (COCH) | United States | $0.037B | 0.00 |
| Spectral AI (MDAI) | United States | $0.034B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.033B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.007B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 17.06 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |